XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Liquidity, Going Concern, and Restatement (Tables)
9 Months Ended
Sep. 30, 2025
Liquidity, Going Concern, and Restatement [Abstract]  
Schedule of Impact of the Restatement

The impact of the restatement on the balance sheets, statements of operations, and statements of cash flows as of and for the nine months ended September 30, 2024 is presented below.

 

   September 30, 2024 
Unaudited Condensed
Consolidated Balance Sheets
  As
Reported
   Adjustments   As
Restated
 
Prepaid expense and other current asset  $91,291   $22,960   $114,251 
Current Assets   2,148,327    22,960    2,171,287 
Property and equipment, net   7,931,478    (7,400,000)   531,478 
Prepayment for asset acquisition   
-
    691,900    691,900 
Total Assets   14,462,845    (6,685,140)   7,777,705 
         -      
Short-term loan   866,250    30,000    896,250 
Accrued expenses and other current liabilities   3,632,927    (42,626)   3,590,301 
Due to related parties   419,270    (30,143)   389,127 
Current Liabilities   6,548,927    (302,016)   6,246,911 
Total Liabilities   6,483,523    (42,769)   6,440,754 
         -      
Additional paid-in capital   87,308,080    (9,053,103)   78,254,977 
Total stockholders’ equity   8,358,466    (6,716,428)   1,642,038 
Noncontrolling interest   (379,144)   74,057    (305,087)
Total Equity   7,979,322    (6,642,371)   1,336,951 
Total Liabilities and Equity  $14,462,845   $(6,685,140)  $7,777,705 

 

   Three Months Ended September 30, 2024 
Unaudited Condensed
Consolidated Statements of Operations
  As
Reported
   Adjustments   As
Restated
 
Selling, general and administrative expenses  $301,208   $256,388   $557,596 
Stock based compensation   
-
    95,875    95,875 
Interest expenses   (219,533)   (896)   (220,429)
Net loss attributable to noncontrolling interests   52,289    (144,951)   (92,662)
Net loss   (134,272)   (353,159)   (487,431)
Basic and diluted net loss per common share  $(0.02)  $(0.02)  $(0.03)
   Nine Months Ended September 30, 2024 
Unaudited Condensed Consolidated
Statements of Operations
  As
Reported
   Adjustments   As
Restated
 
Selling, general and administrative expenses  $1,772,916   $176,949   $1,949,865 
Stock based compensation   2,957,736    (547,355)   2,410,381 
Interest expenses   (1,164,248)   555,064    (609,184)
Net loss attributable to noncontrolling interests   (255,798)   (35,408)   (291,206)
Net loss   (5,132,182)   960,878    (4,171,304)
Basic and diluted net loss per common share   (0.46)   0.09    (0.37)

 

   Nine Months Ended September 30, 2024 
Unaudited Condensed Consolidated
Statements of Cash Flows
  As
Reported
   Adjustments   As
Restated
 
Net loss  $(5,387,980)  $925,470   $(4,462,510)
Stock-based compensation   2,957,736    (547,355)   2,410,381 
Other non-cash income and expenses   1,134,029    (558,559)   575,470 
Prepaid expenses and other deposits   14,177    264,556    278,733 
Accrued expenses and other current liabilities   128,189    (86,240)   41,949 
Due from related parties*   (467,424)   456,789    (10,635)
Due to related parties   246,138    (246,138)   
-
 
Net cash used in operating activities   (1,315,534)   208,523    (1,107,011)
Loan to related parties*   
-
    (456,789)   (456,789)
Net cash used in investing activities*   
-
    (456,789)   (456,789)
Due to related parties*   
-
    215,634    215,634 
Proceeds from short-term borrowings*   
-
    30,000    30,000 
Net cash provided by financing activities  $1,399,313   $245,634   $1,644,947 
                
Issuance of common stock for conversion of debt  $845,715   $(241,493)  $604,222 

 

* Previously reported amount was reclassified to financing activities based on current year’s presentation.